Activation of the Hexosamine Pathway Leads to Phosphorylation of Insulin Receptor Substrate-1 on Ser307 and Ser612 and Impairs the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Insulin Biosynthetic Pathway in RIN Pancreatic β-Cells

Author:

Andreozzi Francesco1,D’Alessandris Cristina2,Federici Massimo2,Laratta Emanuela1,Del Guerra Silvia3,Del Prato Stefano3,Marchetti Piero3,Lauro Renato2,Perticone Francesco1,Sesti Giorgio1

Affiliation:

1. Department of Experimental and Clinical Medicine (F.A., E.L., F.P., G.S.), University of Catanzaro-Magna Græcia, 88100 Catanzaro, Italy

2. Laboratory of Molecular Medicine (C.D., M.F., R.L.), Department of Internal Medicine, University of Rome-Tor Vergata, 00133 Rome, Italy

3. Department of Endocrinology and Metabolism (S.D.G., S.D.P., P.M.), Metabolic Unit, University of Pisa, 56100 Pisa, Italy

Abstract

AbstractMany adverse effects of glucose were attributed to its increased routing through the hexosamine pathway (HBP). There is evidence for an autocrine role of the insulin signaling in β-cell function. We tested the hypothesis that activation of the HBP induces defects in insulin biosynthesis by affecting the insulin-mediated protein translation signaling. Exposure of human pancreatic islets and RIN β-cells to glucosamine resulted in reduction in glucose- and insulin-stimulated insulin biosynthesis, which in RIN β-cells was associated with impairment in insulin-stimulated insulin receptor substrate-1 (IRS-1) phosphorylation at Tyr608 and Tyr628, which are essential for engaging phosphatidylinositol 3-kinase (PI 3-kinase). These changes were accompanied by impaired activation of PI 3-kinase, and activation of Akt/mammalian target of rapamycin/phosphorylated heat- and acid-stable protein-1/p70S6 kinase pathway. RIN β-cells exposed to high glucose exhibited increased c-Jun N-terminal kinase (JNK) and ERK1/2 activity, which was associated with increased IRS-1 phosphorylation at serine (Ser)307 and Ser612, respectively, that inhibits coupling of IRS-1 to the insulin receptor and is upstream of the inhibition of IRS-1 tyrosine phosphorylation. Azaserine reverted the stimulatory effects of high glucose on JNK and ERK1/2 activity and IRS-1 phosphorylation at Ser307 and Ser612. Glucosamine mimicked the stimulatory effects of high glucose on JNK and ERK1/2 activity and IRS-1 phosphorylation at Ser307 and Ser612. Inhibition of JNK and MAPK kinase-1 activity reverted the negative effects of glucosamine on insulin-mediated protein synthesis. These results suggest that activation of the HBP accounts, in part, for glucose-induced phosphorylation at Ser307 and Ser612 of IRS-1 mediated by JNK and ERK1/2, respectively. These changes result in impaired coupling of IRS-1 and PI 3-kinase, and activation of the Akt/mammalian target of rapamycin/phosphorylated heat- and acid-stable protein-1/p70S6 kinase pathway.

Publisher

The Endocrine Society

Subject

Endocrinology

Reference44 articles.

1. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.;Weyer;J Clin Invest,1999

2. Glucose toxicity.;Rossetti;Diabetes Care,1990

3. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the β-cell function.;Eizirik;J Clin Invest,1992

4. The reduction of insulin gene transcription in HIT-T15b cells chronically exposed to high glucose concentration is associated with the loss of RIPE3b1 and SFT-1 transcription factor expression.;Sharma;Mol Endocrinol,1995

5. Prolonged exposure of human β cells to elevated glucose levels results in sustained cellular activation leading to a loss of glucose regulation.;Ling;J Clin Invest,1996

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3